Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

454863

registered interest
date	24/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Meningitis: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to urgently consult with medical authorities on ensuring a meningitis B vaccine is provided to all young children; and if he will make a statement.
tabling member constituency	Walsall North
tabling member printed	Mr David Winnick
uin	28230
answer	answer is ministerial correction date of answer 29/02/2016 answer text <p>National immunisation programmes are introduced on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), the independent expert body that advises the Government on all immunisation matters. JCVI’s recommendations are based on a comprehensive and careful review of a wide range of evidence including information from medical experts.</p><p> </p><p>JCVI reviewed the available evidence on meningitis B vaccine and recommended a national Meningococcal B (MenB) immunisation programme for infants. The MenB vaccine is first offered to babies at 2 months of age, with further doses offered when they reach 4 and 12 months of age.</p><p> </p><p>MenB was introduced into the NHS programme in September 2015. JCVI keeps the eligibility criteria of all vaccination programmes under review and considers new evidence as it becomes available. If JCVI provides further advice about the programme, we will consider this.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 28232 question first answered 29/02/2016 18:21:57 answering member 3918 label Biography information for Jane Ellison
tabling member	316 label Biography information for Mr David Winnick

454866

registered interest
date	24/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Meningitis: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when his Department last consulted medical authorities on the potential merits of making the meningitis B vaccine available on the NHS for all children; and if he will make a statement.
tabling member constituency	Walsall North
tabling member printed	Mr David Winnick
uin	28232
answer	answer is ministerial correction date of answer 29/02/2016 answer text <p>National immunisation programmes are introduced on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), the independent expert body that advises the Government on all immunisation matters. JCVI’s recommendations are based on a comprehensive and careful review of a wide range of evidence including information from medical experts.</p><p> </p><p>JCVI reviewed the available evidence on meningitis B vaccine and recommended a national Meningococcal B (MenB) immunisation programme for infants. The MenB vaccine is first offered to babies at 2 months of age, with further doses offered when they reach 4 and 12 months of age.</p><p> </p><p>MenB was introduced into the NHS programme in September 2015. JCVI keeps the eligibility criteria of all vaccination programmes under review and considers new evidence as it becomes available. If JCVI provides further advice about the programme, we will consider this.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 28230 question first answered 29/02/2016 18:21:57 answering member 3918 label Biography information for Jane Ellison
tabling member	316 label Biography information for Mr David Winnick

454867

registered interest
date	24/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Meningitis: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to meet Mr and Mrs Timmins to discuss the death in 2013 of their son from meningitis B and the future provision of a vaccine for that disease on the NHS; and if he will make a statement.
tabling member constituency	Walsall North
tabling member printed	Mr David Winnick
uin	28231
answer	answer is ministerial correction date of answer 29/02/2016 answer text <p>Meningococcal B (MenB) disease is a devastating disease which can have tragic consequences. We understand that in March 2014 Mr and Mrs Timmins met consultants at Walsall Healthcare NHS Trust to discuss their son’s care following his tragic death in December 2013.</p><p> </p><p>In September 2015, we became the first country in the world to offer a national and publicly funded MenB immunisation programme using the Bexsero vaccine to protect infants. The programme follows the advice of the Joint Committee on Vaccination and Immunisation, the independent, expert body which advises Government on all immunisation matters. Infants are vaccinated at two months of age, with further doses offered when they reach four and 12 months of age, thereby protecting groups with the highest risk.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/02/2016 18:19:05 answering member 3918 label Biography information for Jane Ellison
tabling member	316 label Biography information for Mr David Winnick